Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Aclaris Therapeutics, Inc. (ACRS) vs Oculis Holding AG (OCS)

Aclaris Therapeutics, Inc. and Oculis Holding AG are both Biotechnology companies. Aclaris Therapeutics, Inc. and Oculis Holding AG are of similar size ($589.0M and $579.5M). Oculis Holding AG grew revenue faster over the last twelve months: 65.8% against −51.0%. Aclaris Therapeutics, Inc. has the higher net margin (−921.5% vs −6,870.1%) and the lower return on invested capital (−163.4% vs 0.00%). Across the 17 metrics below, Aclaris Therapeutics, Inc. leads on 10 and Oculis Holding AG on 7.

Valuation

Metric ACRS OCS Biotechnology median
P/E n/m n/m 7.88
P/S 89.44 385.70 11.47
P/B 5.90 2.05 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 78.52 191.30 10.73
Earnings yield (11.26%) (18.77%) (28.84%)
Free cash flow yield (8.46%) (14.56%) (23.03%)

Profitability

Metric ACRS OCS Biotechnology median
Gross margin 12.90% 100.00% 65.16%
Operating margin (1,050.16%) (7,383.66%) 0.00%
Net margin (921.50%) (6,870.05%) 0.00%
Free cash flow margin (756.50%) (5,525.64%) 0.00%
Return on equity (59.10%) (44.87%) (57.72%)
Return on assets (41.07%) (37.69%) (49.22%)
Return on invested capital (163.35%) 0.00% 0.00%

Growth

Metric ACRS OCS Biotechnology median
Revenue growth (TTM) (51.04%) 65.83% 5.64%
EPS growth (last fiscal year) 69.01% 5.39% —
Revenue growth, 5-year CAGR 3.84% — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ACRS OCS Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 3.46 8.35 4.73
Net debt to EBITDA 1.20 2.60 0.96

Dividend

Metric ACRS OCS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric ACRS OCS Biotechnology median
Market cap 588.97m 579.54m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack